Sui讲了一段趣事,他在剑桥做细胞转化讲座的时候,Gurdon迟到但在会后向他道歉。原因不是他摆谱,真正的原因是他以78岁高龄还在亲手做实验!Sui还提到,可惜的是Thomas Graf,他从80年代开始就开始做细胞人工转化的工作,那时的主流意见都不认可细胞转化,因此他破天荒的工作:使用GATA-1将Myeloblast转化为MEP 细胞,却默默不为人知。他向杂志投稿,得到的反馈是 “It is the editorial policy of the journal not to publish articles that are based on overexpression experiments.” 2004年他向MIT的Ruedi Jaenisch (细胞转化领域的另一位牛人, 2011年获得Wolf医学奖) 提议使用皮肤细胞转化为胚胎干细胞。Ruedi Jaenisch断然拒绝,因为他认为chromatin上的化学键改变会使这一转化不可能。Thomas Graf 在Cell:Stem Cell的Review 附于文后。
“‘One of the rare non-surprising and I would say, well-deserved Nobel Prizes in medicine! At least this year it is on a cell that everyone has heard of! Don’t forget Sir John Gurdon (> 78 years old) for his famous textbook experiment (frog intestinal cell nuclear transfer) also got the Noble prize – so that is fair. I am very happy for him. And you are right: in 10 years iPS may be viewed more as an academically interesting research tool of little clinical utility. They are close to cancer attractors, and cases of cancer from stem cell therapy have been reported. Same fate as gene therapy perhaps.
For you as a young scientist this is what I have to say: Don’t take it too seriously, view the NP’s like Oscar–equivalents in science. Focus on what nature tells you is good science, not what humans tell you is good science.NP’s are highly political, and capricious, not only those that go to Obama and Krugman and Carter and Kissinger…. Noble prizes reflect the collective mood and relative ignorance of mankind so one shall not overanalyze them in scientific terms. They are good for communicating once a year to the non-scientists on this planet what is going on in science.
But on the science in this case: As you said, stunningly, both Gurdon and Yamanaka are not so much keen on understanding the underlying systems biology basis of reprogramming. Sir Gurdon, with whom I had the honor to discuss a few times when I gave talks in Cambridge, is at the very least politely, and perhaps even intrinsically, interested in networks and attractors, had sharp provocative qualitative questions but I not am sure if he “gets it”. (e.g.: he believes in trinary and n-ary branching processes which is of courses a mathematically very very unlikely singularity as opposed to binary branching, much as “trifurcation” is not a generic property of dynamical systems as opposed to bifurcation). John Gurdon works (still!) on the mechanisms of erasing epigenetic memory in the sense of chromatin modification. But very admirable, fascinating person. He apologized for joining late in the seminar I was giving because he was still pipetting! (at the age of 78!!).
Yamanaka has been approached many times by Kuni Kaneko (strange attractor = cell type guy) and he told me that Yamanaka is neither interested nor has a clue about attractors. This is of course evident in his attempts to comment on the stochastic nature of reprogramming as we all know.
Also I think the postdoc should be acknowledged, and also Thomas Graf who was lonely for many years in his struggle for recognition of the idea that cells can be reprogrammed across lineages by TF overexpression (following Weintraub’s tradition). Postdocs need to be recognized because: The idea is simple – many a PI has suggested the same experiment of overexpressing Oct4, etc. to their postdocs (e.g. Ruedi Jaenisch has tried to convince his postdocs long before Yamanaka to do it but no one believed in it – they preferred the at that time less pedestrian looking, technically challenging nuclear transfer!). Thus, recognizing the importance of a project and doing it is actually the rate limiting factor in science – not having the idea!! Sadly, in biology, ideas, theory and deep understanding are on the backseat.
So in summary, the lesson for you, is: unlike in physics and math, in biology the doers not the thinkers and those who understand rerum causas get the recognition. But the latter is much more fun! (felix qui potuit cognoscere rerum causas), 知因求果者得其乐)。